| Patent | Date |
|---|
Antibody Molecule-drug Conjugates And Uses Thereof
App 20220267418 - Plante; Obadiah Joseph ; et al. | 2022-08-25 |
Antibody Molecules To A Proliferation-inducing Ligand (april)
App 20220235124 - Myette; James R. ; et al. | 2022-07-28 |
Interleukin-2 Agents And Uses Thereof
App 20220226442 - Carlson; Scott Moore ; et al. | 2022-07-21 |
Methods Of Using Interleukin-2 Agents
App 20220177535 - Carlson; Scott Moore ; et al. | 2022-06-09 |
Antibody Molecules to C5AR1 and Uses Thereof
App 20220089764 - Viswanathan; Karthik ; et al. | 2022-03-24 |
Methods For Identifying Epitopes And Paratopes
App 20220059184 - Wollacott; Andrew M. ; et al. | 2022-02-24 |
Antibody molecule-drug conjugates and uses thereof
Grant 11,168,131 - Plante , et al. November 9, 2 | 2021-11-09 |
Antibody Molecules To April And Uses Thereof
App 20210340266 - Myette; James R. ; et al. | 2021-11-04 |
Antibody Molecule-drug Conjugates And Uses Thereof
App 20210316004 - Viswanathan; Karthik ; et al. | 2021-10-14 |
Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule
Grant 11,136,385 - Myette , et al. October 5, 2 | 2021-10-05 |
Antibody Molecule-drug Conjugates And Uses Thereof
App 20210283220 - Shriver; Zachary ; et al. | 2021-09-16 |
Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)
Grant 10,981,982 - Myette , et al. April 20, 2 | 2021-04-20 |
Antibody molecules to a proliferation-inducing ligand (APRIL)
Grant 10,968,270 - Myette , et al. April 6, 2 | 2021-04-06 |
Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA
Grant 10,954,296 - Myette , et al. March 23, 2 | 2021-03-23 |
Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA
Grant 10,919,960 - Myette , et al. February 16, 2 | 2021-02-16 |
Antibody Molecules To A Proliferation-inducing Ligand (april)
App 20210032324 - Myette; James R. ; et al. | 2021-02-04 |
Interleukin-2 Agents And Uses Thereof
App 20210024601 - Carlson; Scott Moore ; et al. | 2021-01-28 |
Humanized Antibody Molecules To Cd138 And Uses Thereof
App 20200392241 - Chaganty; Bharat ; et al. | 2020-12-17 |
Antibody Molecules To A Proliferation-inducing Ligand (april)
App 20200331995 - Myette; James R. ; et al. | 2020-10-22 |
Antibody Molecules To A Proliferation-inducing Ligand (april)
App 20200317770 - Myette; James R. ; et al. | 2020-10-08 |
Antibody Molecules To A Proliferation-inducing Ligand (april)
App 20200299376 - Myette; James R. ; et al. | 2020-09-24 |
Engineered Polypeptides And Uses Thereof
App 20200277358 - Viswanathan; Karthik ; et al. | 2020-09-03 |
Antibody Molecules To A Proliferation-inducing Ligand (april)
App 20190330326 - Myette; James R. ; et al. | 2019-10-31 |
Antibody molecules to a proliferation-inducing ligand (APRIL)
Grant 10,385,123 - Myette , et al. A | 2019-08-20 |
Antibody Molecules To Cd138 And Uses Thereof
App 20190100588 - Chaganty; Bharat ; et al. | 2019-04-04 |
Antibody Molecules To April And Uses Thereof
App 20190092851 - Myette; James R. ; et al. | 2019-03-28 |
Engineered Polypeptides And Uses Thereof
App 20180037634 - Viswanathan; Karthik ; et al. | 2018-02-08 |
HER2-specific monoclonal antibodies and conjugates thereof
Grant 9,738,726 - Dimitrov , et al. August 22, 2 | 2017-08-22 |
Antibody Molecules To April And Uses Thereof
App 20170145086 - Myette; James R. ; et al. | 2017-05-25 |
Antibody Molecule-drug Conjugates And Uses Thereof
App 20170129942 - Plante; Obadiah Joseph ; et al. | 2017-05-11 |
Her2-specific Monoclonal Antibodies And Conjugates Thereof
App 20160130359 - Dimitrov; Dimiter S. ; et al. | 2016-05-12 |
Alpha 1-3 N-galactosylstransferase with altered donor specificities, compositions and methods of use
Grant 9,222,080 - Qasba , et al. December 29, 2 | 2015-12-29 |
Catalytic Domains Of Beta(1,4)-galactosyltransferase I Having Altered Metal Ion Specificity
App 20150018522 - Qasba; Pradman K. ; et al. | 2015-01-15 |
Beta 1,4-galactosyltransferases With Altered Donor And Acceptor Specificities, Compositions And Methods Of Use
App 20140178985 - Qasba; Pradman K. ; et al. | 2014-06-26 |
Catalytic domains of beta(1,4)-galactosyltransferase I having altered metal ion specificity
Grant 8,703,459 - Qasba , et al. April 22, 2 | 2014-04-22 |
Alpha 1-3 N-galactosylstransferase With Altered Donor Specificities, Compositions And Methods Of Use
App 20130243690 - Qasba; Pradman K. ; et al. | 2013-09-19 |
Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use
Grant 8,512,991 - Qasba , et al. August 20, 2 | 2013-08-20 |
Alpha 1-3 N-galactosyltransferase with altered donor specificities
Grant 8,425,901 - Qasba , et al. April 23, 2 | 2013-04-23 |
Alpha 1-3 N-galactosyltransferase With Altered Donor Specificities
App 20110217235 - Qasba; Pradman K. ; et al. | 2011-09-08 |
Beta 1,4-galactosyltransferases With Altered Donor And Acceptor Specificities, Compositions And Methods Of Use
App 20110064663 - Qasba; Pradman K. ; et al. | 2011-03-17 |
Catalytic domains of beta(1,4)-galactosyl transferase i having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use
App 20090233345 - Qasba; Pradman ; et al. | 2009-09-17 |
Catalytic domains of .beta.(1,4)-galactosyltransferase I having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use
Grant 7,482,133 - Qasba , et al. January 27, 2 | 2009-01-27 |
Catalytic Domains Of Beta(1,4)-Galactosyltransferase I Having Altered Metal Ion Specificity
App 20080199905 - Qasba; Pradman ; et al. | 2008-08-21 |
Targeted Delivery System for Bioactive Agents
App 20070258986 - Qasba; Pradman ; et al. | 2007-11-08 |
Catalytic domains of beta(1,4)-galactosyltransferase I having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use
App 20060084162 - Qasba; Pradman ; et al. | 2006-04-20 |
| 